Autopsy report · NCT01845974

Atrial Pressure Electrophysiology Pilot Study

“Interim evaluation of data after internal safety report from sponsor.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 7 months before it stopped.
• 13 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Wake Forest University Health Sciences

Sponsor type

University, hospital or other

Conditions

Atrial Fibrillation

Interventions

ThermoCool® SF NAV Catheter; ThermoCool® catheter

Participants

13

Sites

1

Countries

United States

Trials that died the same way

• Timing for Removal of Chest Tubes in Adult Cardiac Surgery
  “Safety interim analysis” (67% match in meaning)
• Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
  “Study terminated based on evaluation of safety data.” (65% match in meaning)
• A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys
  “Interim results suggested a concern for patient outcomes and safety” (63% match in meaning)
• Study of Ataluren (PTC124) in Hemophilia A and B
  “Study was terminated early due to Sponsor decision and not reflective of adverse safety findings.” (60% match in meaning)
• Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy
  “This study was terminated based on preliminary safety data.” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.